Close



Jan 29, 2023 10:26PM
Jan 29, 2023 09:55PM
Nov 10, 2022 02:45PM
Nov 10, 2022 02:15PM
Oct 31, 2022 09:01AM
Oct 31, 2022 09:00AM
Sep 29, 2022 09:00AM Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
Aug 31, 2022 05:41AM
Aug 30, 2022 11:21PM
Aug 23, 2022 09:00AM
Aug 17, 2022 09:00AM
Aug 16, 2022 09:00AM
Jul 7, 2022 09:30AM
Jul 7, 2022 09:30AM Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc.
Jul 5, 2022 02:04PM
Jun 14, 2022 10:37AM
Jun 14, 2022 10:33AM
Jun 3, 2022 09:02AM
Jun 3, 2022 09:00AM
Jun 2, 2022 09:00AM
May 18, 2022 09:30AM Sorrento's (SRNE) Scilex to Initiate Phase 2 Study of SP-103
May 18, 2022 09:30AM
May 16, 2022 09:04AM
May 16, 2022 09:00AM
May 11, 2022 09:01AM
May 11, 2022 09:00AM
May 5, 2022 08:05PM
Apr 28, 2022 09:00AM Scilex Holding Company a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., Appoints Highly Accomplished Life Science Executive, Elizabeth Czerepak, as Executive Vice President, Chief Financial
Apr 27, 2022 09:00AM
Apr 25, 2022 12:48PM
Apr 25, 2022 12:46PM
Apr 25, 2022 09:00AM
Apr 13, 2022 05:40AM
Apr 12, 2022 09:15PM
Apr 4, 2022 09:03AM Sorrento Therapeutics' (SRNE) Scilex Reports March 2022 Prelim ZTlido Sales of $8.1M, $18.4M For Q1 2022
Apr 4, 2022 09:00AM
Mar 25, 2022 09:03AM
Mar 25, 2022 09:00AM
Mar 23, 2022 12:07PM
Mar 18, 2022 09:02AM
Mar 18, 2022 09:00AM
Mar 17, 2022 03:36PM Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento (SRNE), to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I (VCKA)
Mar 17, 2022 03:35PM
Feb 17, 2022 01:06PM
Feb 17, 2022 01:02PM
Feb 1, 2022 09:00AM
Dec 20, 2021 09:00AM
Dec 9, 2021 09:03AM
Dec 9, 2021 09:00AM Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.
Dec 6, 2021 09:02AM

924,116 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All